ARCHIVES

In Brief: Oldham to Leave NCI, Herberman Acting Head Of BRMP; Lansky Appointed Director Of ICC

This article is from The Cancer Letter archive.

Vol. 09 No. 43 | November 11, 1983

Download PDF Visit The Full Archive

Related Articles

In Brief: Congress Sets NCI Rescission At $10.785 Million; Centers to Be Funded According To Priority Scores

June 12, 1981

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

January 20, 2006

NCI To Recomplete CIDAC Contracts

September 23, 1977

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

July 29, 2011

Biotech Organization Endorses Measures On Orphan Drug Act

April 1, 1994

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011